1
|
Yuan M, Wang J, Geng L, Wu N, Yang Y, Zhang Q. A review: Structure, bioactivity and potential application of algal polysaccharides in skin aging care and therapy. Int J Biol Macromol 2024; 272:132846. [PMID: 38834111 DOI: 10.1016/j.ijbiomac.2024.132846] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2023] [Revised: 05/06/2024] [Accepted: 05/31/2024] [Indexed: 06/06/2024]
Abstract
Skin is the first barrier of body which stands guard for defending aggressive pathogens and environmental pressures all the time. Cutaneous metabolism changes in harmful exposure, following with skin dysfunctions and diseases. Lots of researches have reported that polysaccharides extracted from seaweeds exhibited multidimensional bioactivities in dealing with skin disorder. However, few literature systematically reviews them. The aim of the present paper is to summarize structure, bioactivities and structure-function relationship of algal polysaccharides acting on skin. Algal polysaccharides show antioxidant, immunomodulating, hydration regulating, anti-melanogenesis and extracellular matrix (ECM) regulating abilities via multipath ways in skin. These bioactivities are determined by various parameters, including seaweed species, molecular weight, monosaccharides composition and substitute groups. In addition, potential usages of algae-derived polysaccharides in skin care and therapy are also elaborated. Algal polysaccharides are potential ingredients in formulation that providing anti-aging efficacy for skin.
Collapse
Affiliation(s)
- Mengyao Yuan
- CAS and Shandong Province Key Laboratory of Experimental Marine Biology, Center for Ocean Mega-Science, Institute of Oceanology, Chinese Academy of Sciences, 7 Nanhai Road, Qingdao 266071, China; University of Chinese Academy of Sciences, Beijing 100049, PR China
| | - Jing Wang
- CAS and Shandong Province Key Laboratory of Experimental Marine Biology, Center for Ocean Mega-Science, Institute of Oceanology, Chinese Academy of Sciences, 7 Nanhai Road, Qingdao 266071, China; Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, 168 Wenhai Road, Qingdao 266237, China.
| | - Lihua Geng
- CAS and Shandong Province Key Laboratory of Experimental Marine Biology, Center for Ocean Mega-Science, Institute of Oceanology, Chinese Academy of Sciences, 7 Nanhai Road, Qingdao 266071, China; Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, 168 Wenhai Road, Qingdao 266237, China
| | - Ning Wu
- CAS and Shandong Province Key Laboratory of Experimental Marine Biology, Center for Ocean Mega-Science, Institute of Oceanology, Chinese Academy of Sciences, 7 Nanhai Road, Qingdao 266071, China; Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, 168 Wenhai Road, Qingdao 266237, China
| | - Yue Yang
- CAS and Shandong Province Key Laboratory of Experimental Marine Biology, Center for Ocean Mega-Science, Institute of Oceanology, Chinese Academy of Sciences, 7 Nanhai Road, Qingdao 266071, China; Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, 168 Wenhai Road, Qingdao 266237, China
| | - Quanbin Zhang
- CAS and Shandong Province Key Laboratory of Experimental Marine Biology, Center for Ocean Mega-Science, Institute of Oceanology, Chinese Academy of Sciences, 7 Nanhai Road, Qingdao 266071, China; Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, 168 Wenhai Road, Qingdao 266237, China
| |
Collapse
|
2
|
Pramanik S, Singh A, Abualsoud BM, Deepak A, Nainwal P, Sargsyan AS, Bellucci S. From algae to advancements: laminarin in biomedicine. RSC Adv 2024; 14:3209-3231. [PMID: 38249671 PMCID: PMC10797329 DOI: 10.1039/d3ra08161c] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2023] [Accepted: 12/22/2023] [Indexed: 01/23/2024] Open
Abstract
Laminarin, a complicated polysaccharide originating from brown algae, has emerged as a compelling candidate in the domain of biomedical research. This enigmatic molecule, composed of glucose units associated with both β-1,3 and β-1,6 glycosidic bonds, possesses an array of remarkable characteristics that render it auspicious for multifaceted biomedical applications. This review investigates the comprehensive potential of laminarin in the biomedical domain, emphasizing its remarkable biocompatibility, low cytotoxicity, and cell proliferation support. Laminarin's immunomodulatory attributes position it as an encouraging contender in immunotherapy and the development of vaccines. Moreover, its anti-inflammatory and antioxidant characteristics provide a promising avenue for combatting conditions associated with oxidative stress. In particular, laminarin excels as a drug delivery vehicle owing to its exceptional encapsulation capabilities emerging from its porous framework. Integrating pH and redox responsiveness in laminarin-based drug delivery systems is poised to redefine targeted therapies. Laminarin substantially contributes to tissue engineering by improving adhesion, migration of cells, and deposition of extracellular matrix. This augmentation magnifies the regenerative capability of tissue-engineered constructs, substantiated by the advancement of laminarin-based wound dressings and tissue scaffolds, marking considerable progress in the domain of wound healing and tissue regeneration. While laminarin exhibits substantial potential in biomedical applications, it remains in the initial phases of exploration. Comprehensive preclinical and clinical research is warranted to verify its effectiveness and safety across various applications. In essence, laminarin, a marine marvel, has the capability to remodel biomedical research, offering inventive solutions to complex difficulties.
Collapse
Affiliation(s)
- Sheersha Pramanik
- Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras Chennai 600036 Tamil Nadu India
| | - Anshul Singh
- Department of Chemistry, Baba Mastnath University Rohtak 124021 India
| | - Bassam M Abualsoud
- Department of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, Al-Ahliyya Amman University Amman 19328 Jordan
| | - A Deepak
- Saveetha Institute of Medical and Technical Sciences, Saveetha School of Engineering Chennai Tamil Nadu 600128 India
| | - Pankaj Nainwal
- School of Pharmacy, Graphic Era Hill University Dehradun 248001 India
| | - Armen S Sargsyan
- Scientific and Production Center "Armbiotechnology" NAS RA 14 Gyurjyan Str. Yerevan 0056 Armenia
| | - Stefano Bellucci
- INFN-Laboratori Nazionali di Frascati Via E. Fermi 54 00044 Frascati Italy
| |
Collapse
|
3
|
Huang CC, Lo YH, Hsu YJ, Cheng YB, Kung CC, Liang CW, Chang DC, Wang KL, Hung CF. Anti-Atopic Dermatitis Activity of Epi-Oxyzoanthamine Isolated from Zoanthid. Mar Drugs 2023; 21:447. [PMID: 37623728 PMCID: PMC10456062 DOI: 10.3390/md21080447] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2023] [Revised: 08/10/2023] [Accepted: 08/10/2023] [Indexed: 08/26/2023] Open
Abstract
Atopic dermatitis (AD, eczema) is a condition that causes dry, itchy, and inflamed skin and occurs most frequently in children but also affects adults. However, common clinical treatments provide limited relief and have some side effects. Therefore, there is a need to develop new effective therapies to treat AD. Epi-oxyzoanthamine is a small molecule alkaloid isolated from Formosan zoanthid. Relevant studies have shown that zoanthamine alkaloids have many pharmacological and biological activities, including anti-lymphangiogenic functions. However, there are no studies on the use of epi-oxyzoanthamine on the skin. In this paper, epi-oxyzoanthamine has been shown to have potential in the treatment of atopic dermatitis. Through in vitro studies, it was found that epi-oxyzoanthamine inhibited the expression of cytokines in TNF-α/IFN-γ-stimulated human keratinocyte (HaCaT) cells, and it reduced the phosphorylation of MAPK and the NF-κB signaling pathway. Atopic dermatitis-like skin inflammation was induced in a mouse model using 2,4-dinitrochlorobenzene (DNCB) in vivo. The results showed that epi-oxyzoanthamine significantly decreased skin barrier damage, scratching responses, and epidermal hyperplasia induced by DNCB. It significantly reduced transepidermal water loss (TEWL), erythema, ear thickness, and spleen weight, while also increasing surface skin hydration. These results indicate that epi-oxyzoanthamine from zoanthid has good potential as an alternative medicine for treating atopic dermatitis or other skin-related inflammatory diseases.
Collapse
Affiliation(s)
- Chieh-Chen Huang
- School of Medicine, Fu Jen Catholic University, New Taipei City 242, Taiwan; (C.-C.H.); (Y.-H.L.); (C.-C.K.); (C.-W.L.)
- Department of Dermatology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei 111, Taiwan
| | - Yuan-Hsin Lo
- School of Medicine, Fu Jen Catholic University, New Taipei City 242, Taiwan; (C.-C.H.); (Y.-H.L.); (C.-C.K.); (C.-W.L.)
- Department of Dermatology, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei City 242, Taiwan
| | - Yu-Jou Hsu
- PhD Program in Pharmaceutical Biotechnology, Fu Jen Catholic University, New Taipei City 24205, Taiwan;
| | - Yuan-Bin Cheng
- Department of Marine Biotechnology and Resources, National Sun Yat-Sen University, Kaohsiung 804, Taiwan;
| | - Chia-Chi Kung
- School of Medicine, Fu Jen Catholic University, New Taipei City 242, Taiwan; (C.-C.H.); (Y.-H.L.); (C.-C.K.); (C.-W.L.)
- Department of Anesthesiology, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei City 242, Taiwan
| | - Cher-Wei Liang
- School of Medicine, Fu Jen Catholic University, New Taipei City 242, Taiwan; (C.-C.H.); (Y.-H.L.); (C.-C.K.); (C.-W.L.)
- Department of Pathology, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei City 242, Taiwan
| | - Der-Chen Chang
- Department of Mathematics and Statistics, Department of Computer Science, Georgetown University, Washington, DC 20057, USA;
| | - Kang-Ling Wang
- Division of Metabolism and Endocrinology, Department of Internal Medicine, Taoyuan Armed Forces General Hospital, Taoyuan 325, Taiwan
| | - Chi-Feng Hung
- School of Medicine, Fu Jen Catholic University, New Taipei City 242, Taiwan; (C.-C.H.); (Y.-H.L.); (C.-C.K.); (C.-W.L.)
- School of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
| |
Collapse
|